Epidemiology, Microbiological and Clinical Features, Treatment, and Outcomes of Infective Endocarditis in Crete, Greece.
- Author:
Panteleimon E PAPAKONSTANTINOU
1
;
George SAMONIS
;
Angeliki M ANDRIANAKI
;
Maria CHRISTOFAKI
;
Dimitra DIMOPOULOU
;
John PAPADAKIS
;
Achilleas GIKAS
;
Diamantis P KOFTERIDIS
Author Information
- Publication Type:Original Article
- Keywords: Endocarditis; Epidemiology; Staphylococcus; Treatment outcome; Prosthetic valve endocarditis
- MeSH: Coxiella burnetii; Endocarditis*; Enterococcus; Epidemiology*; Gemella; Greece*; Humans; Medical Records; Retrospective Studies; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Systemic Inflammatory Response Syndrome; Treatment Outcome
- From:Infection and Chemotherapy 2018;50(1):21-28
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: This study aimed to evaluate the epidemiology, clinical and microbiological features, treatment, and outcomes of infective endocarditis (IE) on the island of Crete, a region with high levels of antimicrobial resistance. MATERIALS AND METHODS: Medical records of all hospitalized patients diagnosed with IE at the University Hospital of Heraklion, Crete, Greece, from 1995 to 2015, were retrospectively reviewed. Patients who met the modified Duke's criteria for definite or possible IE were included. RESULTS: A total of 82 IE patients (median age 67 [range 21–86] years) were included. Most patients suffered from left-sided IE (94%), while most cases of infection occurred in native valves (53.6%). Systemic inflammatory response syndrome criteria were lacking in almost half of the patient population. The leading causative microorganism was Staphylococcus aureus, isolated in 24 cases (29%), followed by Streptococcus spp. in 15 (18%) and Enterococcus spp. in 12 (14.5%). A number of rare and difficult to treat microorganisms had been identified, such as Gemella morbillorum in four cases (4.5%), Streptococcus lugdunensis in two (2.5%) and Streptococcus pneumoniae in one (1%). One patient was serologically positive for Coxiella burnetii (1%). All patients received empirical antimicrobial treatment, proven appropriate in 39 blood culture-positive patients (56.5%). Thirteen (16%) patients were classified as culture negative. Seven patients (8.5%) were surgically treated. In-hospital death occurred in 9 patients (11%). CONCLUSION: Changes in IE profile requires continuous epidemiological updates. Staphylococcus and Streptococcus spp. remain the most common etiologic agents. However, the presence of uncommon and/or difficult to treat pathogens raise concerns on the appropriate prophylaxis as well as empirical treatment.
